Analytical Data
-
Gene name
GRK6
- Application
-
Alternative Names
GPRK6; G protein-coupled receptor kinase GRK6
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P43250
-
Expression Region
Phe186~Phe448
-
Molecular Weight
34kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GRK6, or G protein-coupled receptor kinase 6, is a member of the GRK family that plays a crucial role in the regulation of G protein-coupled receptors (GPCRs), which are vital for various physiological processes. The research background on GRK6 highlights its significance in modulating receptor desensitization, internalization, and signaling pathways, ultimately influencing cellular responses to external stimuli. GRK6 has been implicated in several diseases, including heart failure, cancer, and neurological disorders, making it a potential therapeutic target. Previous studies have shown that GRK6 can phosphorylate specific residues on GPCRs, thereby altering their functionality. Furthermore, the expression levels and activity of GRK6 are often dysregulated in pathological conditions, leading to heightened receptor activity or resistance to certain therapies. Understanding the molecular mechanisms of GRK6, including its structure, function, and interactions with other cellular proteins, is crucial for developing novel drugs that can modulate its activity. Research into recombinant GRK6 proteins facilitates investigations into these mechanisms, offering insights into how GRK6 contributes to disease pathogenesis and providing a foundation for targeted therapeutic strategies aimed at restoring normal GPCR signaling in various clinical contexts. Efforts to express and purify GRK6 as a recombinant protein also pave the way for structural studies, which can reveal the conformational dynamics and activation states of this kinase in relation to its substrates and regulators. Overall, GRK6 represents a promising area of research with significant implications for understanding GPCR biology and its relevance in health and disease.
